Search - tctmd.com

Displaying 61 - 80 of 195

Sort: Relevancy | Date

News Daily News

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

July 13, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

July 13, 2015

News Daily News

FDA 批准坎格雷洛作为 PCI 的抗血小板治疗方案

June 29, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

June 29, 2015

News Daily News

ACCOAST分析发现了NSTE-ACS患者更高出血风险的有关因素

June 22, 2015

News Daily News

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

June 22, 2015

News Daily News

替卡格雷预治疗有助于预防 NSTE-ACS 围手术期心肌坏死

June 04, 2015

News Daily News

Ticagrelor Pretreatment May Help Protect Against Periprocedural Myonecrosis in NSTE-ACS

June 04, 2015

News Daily News

活化凝血时间可能预测单纯使用肝素的 PCI 的缺血事件

April 28, 2015

News Daily News

Activated Clotting Time May Predict Ischemic Events in PCI Patients on Heparin Alone

April 28, 2015

News Daily News

Study Quantifies Costs Arising From Thrombotic Events During PCI for NSTE-ACS

April 09, 2015

News Conference News ACC 2015

Early Invasive Strategy Dramatically Lowers Risk of Death, MI in Older NSTE-ACS Patients

March 16, 2015

News Daily News

Analysis of SYNTAX Patients Documents Underuse of OMT

March 05, 2015

News Daily News

破裂斑块预示着ACS患者的预后更差

March 04, 2015

News Daily News

用药安全性和基于指南使用抗血栓药均与 NSTE-ACS 结局相关

Yael L. Maxwell

March 04, 2015

News Daily News

Ruptured Plaque Signals Worse Prognosis in ACS Patients

March 04, 2015

News Daily News

Both Dosing Safety, Guideline-Based Use of Antithrombotics Related to NSTE-ACS Outcomes

Yael L. Maxwell

March 04, 2015

News Daily News

Registry Data Suggest Net Clinical Benefit From Pretreating STEMI Patients With Clopidogrel

February 05, 2015

News Daily News

登记研究：从各种表现看，经桡动脉似乎都优于经股动脉PCI

January 28, 2015

News Daily News

亚组分析表明，侵入性策略对老年NSTE-ACS患者的效果更好

January 28, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.